123I thyroid uptake and thyroid size at 24, 48, and 72 hours after the administration of recombinant human thyroid-stimulating hormone to normal volunteers

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 2, 2006, Pages 506-510

  Pena, Samara ^a   Arum, Seth ^a   Cross, Mary ^a   Magnani, Barbarajean ^a   Pearce, Elizabeth N ^a,b   Oates, M Elizabeth ^a   Braverman, Lewis E ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b Section of Endocrinology Diabetes and Nutrition   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 123; IODINE 131; RECOMBINANT THYROTROPIN; LIOTHYRONINE; RADIOACTIVE IODINE; RECOMBINANT PROTEIN; THYROGLOBULIN; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); ELECTROCARDIOGRAM; FEMALE; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; THYROID FUNCTION TEST; THYROID WEIGHT; THYROTROPIN BLOOD LEVEL; ULTRASOUND; BLOOD; DRUG EFFECT; ECHOGRAPHY; ELECTROCARDIOGRAPHY; HISTOLOGY; ORGAN SIZE; THYROID GLAND;

ADULT; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; ORGAN SIZE; RECOMBINANT PROTEINS; THYROGLOBULIN; THYROID FUNCTION TESTS; THYROID GLAND; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 32544440441     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2005-1986     Document Type: Article

References (26)

1. Wartofsky L 2002 Management of low risk well differentiated thyroid cancer based only on thyroglobulin measurement after recombinant human thyrotropin. Thyroid 12:583-590
2. Barbaro D, Boni G, Meucci G, Simi U, Lapi P, Orsini P, Pasquini C, Piazza F, Caciagli M, Mariani G 2003 Radioidine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation. J Clin Endocrinol Metab 88:4110-4115
3. Albino CC, Mesa CO, Olandoski M, Ueda CE, Woellner LC, Goedert CA, Souza AM, Graf H 2005 Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine. J Clin Endocrinol Metab 90:2775-2780
4. Huysmans DA, Nieuwlaat WA, Erdtsieck RJ, Schellekens AP, Bus JW, Bravenboer B, Hermus HR 2000 Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter. J Clin Endocrinol Metab 85:3592-3596
5. 131I therapy of patients with nodular goiter: an evaluation by a randomized double-blinded trial. J Clin Endocrinol Metab 90:79-83
6. Nieuwlaat WA, Hermus AR, Sivro-Prndelj F, Corstens FH, Huysmans DA 2001 Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters. J Clin Endocrinol Metab 86:5330-5336
7. Nieuwlaat WA, Huysmans DA, Bosch H, Sweep CGF, Ross A, Corstens FH, Hermus AR 2003 Pretreatment with a single low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter. J Clin Endocrinol Metab 88:3121-3129
8. Nieuwlaat WA, Hermus AR, Ross HA, Buijs WC, Edelbroek MA, Bus JW, Corstens F, Huysmans D 2004 Dosimetry of radioidine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid stimulating hormone. J Nucl Med 45:626-633
9. 131I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal. J Clin Endocrinol Metab 87:4063-4068
10. Perros P 1999 Recombinant human thyroid stimulating hormone (rhTSH) in the radioablation of well differentiated thyroid cancer: preliminary therapeutic experience. J Endocrinol Invest 22:30-34
11. Robbins RJ, Larson SM, Sinha N, Shaha A, Divgi C, Pentlow KS, Ghossein R, Tuttle RM 2002 A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine remnant ablation. J Nucl Med 43:1482-1488
12. Robbins RJ, Tuttle RM, Sonenberg M, Shaha A, Sharaf R, Robbins H, Fleisher M, Larson SM 2001 Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin. Thyroid 11:865-869
13. Silva NA, Rubio IGS, Romao R, Gebrin E, Buchpiguel C, Tomimori E, Camargo R, Cardia M, Medeiros-Neto G 2004 Administration of a single dose of recombinant human thyrotropin enhances the efficacy of radioiodine treatment of large compressive multinodular goiters. Clin Endocrinol (Oxf) 60:300-308
14. Nielsen V, Bonnema S, Hegedus L 2004 The effects of recombinant human thyrotropin in normal subjects and patients with goitre. Clin Endocrinol (Oxf) 61:655-663
15. Torres MS, Ramirez L, Simkin PH, Braverman LE, Emerson CH 2001 Effect of various doses of recombinant human thyrotropin on the radioactive iodine uptake and serum levels of thyroid hormones and thyroglobulin in normal subjects. J Clin Endocrinol Metab 86:1660-1664
16. Ramirez L, Braverman LE, White B, Emerson CH 1997 Recombinant human thyrotropin is a potent stimulator of thyroid function in normal subjects. J Clin Endocrinol Metab 82:2836-2839
17. Weiss SJ, Philip HJ, Ambesi-Impiombato FS, Grollman EF 1984 Thyrotropin-stimulated iodide transport mediated by adenosine 3′,5′-monophosphate and dependent on protein synthesis. Endocrinology 114:1099-1107
18. Kogai T, Endo T, Saito T, Miyazaki A, Kawaguchi A, Onaya T 1997 Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells. Endocrinology 138:2227-2232
19. Duick DS, Baskin HJ 2004 Significance of radioiodine uptake at 72 hours versus 24 hours after pretreatment with recombinant human thyrodtropin for enhancement of radioiodine therapy in patients with symptomatic nontoxic or toxic nodular goiter. Endocr Pract 10:253-260
20. Duick DS, Baskin HJ 2003 Utility of recombinant human thyrotropin for augmentation of radioiodine uptake and treatment of nontoxic and toxic multinodular goiters. Endocr Pract 9:204-209
21. Brunn J, Block U, Ruf G, Bos I, Kunze WP, Scriba PC 1981 Volumetric der Schilddrüsenlappenmittels. Dtsch Med Wochenschr 106:1338-1340
22. Nielsen V, Bonnema S, Hegedus L 2004 The effects of recombinant human thyrotropin on thyroid size and function in normal subjects: a randomized, double-blind, cross-over trial. J Clin Endocrinol Metab 89:2242-2247
23. Nielsen VE, Bonnema S, Hegedus L 2005 Transient goiter enlargement after administration of 0.3 mg recombinant human thyrotropin in patients with nontoxic nodular goiter: a randomized, double-blind, cross-over trial. Thyroid 15(Suppl 1):S118
24. Silva MN, Rubio IG, Knobel M, et al. 2000 Treatment of multinodular goiters in elderly patients with therapeutic doses of radioiodine preceded by stimulation with human recombinant TSH. Endocr J 47(Suppl):144
25. Romao R, Cardia MS, Watanabe T, Gebrim E, Tomimori E, Camargo R, Knobel M, Medeiros-Neto G 2005 Outpatient radioiodine treatment in multinodular goiter preceded by recombinant human thyrotropin. Thyroid 15(Suppl 1):S214
26. 131I) in multinodular goiter treatment: comparison among 2 therapeutic options. Thyroid 15(Suppl 1):S212